University of California, Los Angeles, Department of Hematology and Oncology — Los Angeles, California

University of California, Los Angeles, Department of Hematology and Oncology is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

University of California, Los Angeles, Department of Hematology and Oncology has participated in 1 clinical trials.

Therapeutic areas: Bone Marrow Failure Syndromes, Anemia, Aplastic, Myelodysplastic Syndromes.

Sponsors: Office of Rare Diseases (ORD).

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California, Los Angeles, Department of Hematology and Oncology?

University of California, Los Angeles, Department of Hematology and Oncology has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California, Los Angeles, Department of Hematology and Oncology conducted?

University of California, Los Angeles, Department of Hematology and Oncology has 1 clinical trials on record. Their work covers Bone Marrow Failure Syndromes, Anemia, Aplastic, Myelodysplastic Syndromes.

Is University of California, Los Angeles, Department of Hematology and Oncology accredited by Crixeo Health?

University of California, Los Angeles, Department of Hematology and Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California, Los Angeles, Department of Hematology and Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.